PDCD1 and neoplasm: Mice with B16-K-OVA-gp33 tumor were treated with OT-I T cells with or without PD-1 blockade, and the frequencies of tumor infiltrating OT-I T cells and of T cells targeting other tumor antigens were determined by TCR specificity inference with the empirical data.